http://medicalxpress.com/ en-us Medical Xpress internet news portal provides the latest news on Health and Medicine. A multi-center Phase III clinical trial demonstrates that Abraxane (nab-paclitaxel) plus gemcitabine is the first combination of cancer drugs to extend survival of late-stage pancreatic cancer patients compared to standard treatment. http://medicalxpress.com/news/2013-01-drug-combination-pancreatic-cancer-patient.html Cancer Tue, 22 Jan 2013 18:00:01 EST news278097991 A new cancer drug combination demonstrated significant improvement in overall survival of late-stage pancreatic cancer patients compared to those receiving standard treatment, according to results of a Phase III clinical trial led by physicians from Scottsdale Healthcare's Virginia G. Cancer Center Clinical Trials, a partnership with the Translational Genomics Research Institute (TGen). http://medicalxpress.com/news/2012-11-phase-iii-worldwide-drug-patients.html Cancer Mon, 19 Nov 2012 13:14:23 EST news272553254 (Medical Xpress)—Results of a University of Arizona Cancer Center's scientist-led clinical trial show that a drug already approved for breast and lung cancer improved progression-free survival in patients with metastatic melanoma. http://medicalxpress.com/news/2012-11-cancer-drug-survival-patients-metastatic.html Cancer Wed, 14 Nov 2012 08:20:40 EST news272103570 (HealthDay)—Abraxane (paclitaxel protein-bound) has been approved by the U.S. Food and Drug Administration—in combination with the drug carboplatin—to treat advanced or spreading non-small cell lung cancer among people who aren't candidates for surgery or radiation therapy, the agency said Friday. http://medicalxpress.com/news/2012-10-abraxane-advanced-lung-cancer.html Cancer Sun, 14 Oct 2012 06:33:08 EST news269415178